Transcriptomics

Dataset Information

0

Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma


ABSTRACT: Translocation renal cell carcinoma (tRCC) is a poorly-characterized subtype of kidney cancer driven by MiT/TFE gene fusions. Here, we define the landmarks of tRCC through an integrative analysis of 152 patients with tRCC identified across multiple genomic, clinical trial, and retrospective cohorts. Most tRCCs harbor few somatic alterations apart from MiT/TFE fusions and homozygous deletions at chromosome 9p21.3 (19.2% of cases). Transcriptionally, tRCCs display a heightened NRF2-driven antioxidant response that is associated with resistance to many targeted therapies. Consistently, we find that outcomes for patients with tRCC treated with vascular endothelial growth factor receptor inhibitors (VEGFR-TKI) are worse than those treated with immune checkpoint inhibition (ICI). Multiparametric immunofluorescence confirmed the presence of CD8+ tumor-infiltrating T cells compatible with a clinical benefit from ICI and revealed an exhaustion immunophenotype distinct from that of clear cell RCC. Our findings comprehensively define the clinical and molecular features of tRCC and may inspire new therapeutic hypotheses.

ORGANISM(S): Homo sapiens

PROVIDER: GSE188885 | GEO | 2021/11/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-10-01 | E-MTAB-13900 | biostudies-arrayexpress
2024-01-04 | GSE252047 | GEO
2021-01-27 | GSE157472 | GEO
2024-08-10 | GSE266517 | GEO
2015-04-03 | E-GEOD-62077 | biostudies-arrayexpress
2020-04-14 | GSE124754 | GEO
2015-04-03 | GSE62077 | GEO
2023-09-01 | GSE237407 | GEO
2020-07-15 | PXD015331 | Pride
2022-03-28 | GSE178665 | GEO